Brief: Acumen Pharmaceuticals, Inc. Q2 Income From Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million
12/08/2026 12:01
BRIEF-Acumen Pharmaceuticals, Inc. Q2 Income From Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million Aug 12 (Reuters) - Acumen Pharmaceuticals, Inc. Q2 operating expenses USD 32.556 million.
- Q2 basic EPS USD -0.45
- Q2 net income USD -32.718 million vs. IBES estimate USD -23.3 million